News

Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health ...
We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where ...
We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Elevance Health (ELV – Research Report). The ...
ELEVANCE HEALTH INC (ELV) is a large-cap growth stock in the Insurance (Accident & Health) industry. The rating using this strategy is 60% based on the firm’s underlying fundamentals and the ...
On April 9, 2025, Elevance Health, Inc. (NYSE:ELV) stock closed at $435.68 per share with a market capitalization of $98.632 billion. GreensKeeper Asset Management stated the following regarding ...
A total of 8 analyst ratings have been received for Elevance Health, with the consensus rating being Outperform. The average ...
At Stock Options Channel, our YieldBoost formula has looked up and down the ELV options chain for the new August 15th contracts and identified one put and one call contract of particular interest.
The stock continues to face pressure regardless of the positive outlook, but that’s precisely what makes it a good buying opportunity. Overall, ELV ranks 20th on our list of top falling stocks ...
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and ...
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and ...